Baader Bank Aktiengesellschaft’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,770
Closed -$728K 433
2026
Q1
$728K Sell
11,770
-12,014
-51% -$961K 0.06% 214
2025
Q4
$2.24M Buy
23,784
+12,598
+113% +$1.24M 0.15% 106
2025
Q3
$1.08M Buy
11,186
+2,997
+37% +$310K 0.07% 177
2025
Q2
$830K Sell
8,189
-2,127
-21% -$215K 0.06% 191
2025
Q1
$1.01M Buy
10,316
+1,696
+20% +$171K 0.08% 171
2024
Q4
$770K Sell
8,620
-997
-10% -$87.8K 0.05% 189
2024
Q3
$782K Buy
+9,617
New +$758K 0.05% 199

Other funds holding BSX

Baader Bank Aktiengesellschaft's BSX Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 11,770 shares — an estimated $728K sold.

Baader Bank Aktiengesellschaft first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $2.24M in Q4 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 11,770 Boston Scientific shares in Q2 2026, an estimated $728K.
  • Baader Bank Aktiengesellschaft first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
  • Baader Bank Aktiengesellschaft's Boston Scientific position peaked at $2.24M in Q4 2025.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.